Abstract
The height of the epidemic peaks varied ten-fold, but the duration was almost constant independent of the peak height in the six times COVID-19 epidemics in Japan over the past two years. The observed relation between the peak height and duration contradicts the inverse proportionality, which is the essential conclusion derived from mathematical models for infectious diseases. We found that the peak height was inversely proportional to the number of rhinovirus patients. The literature has revealed the mechanism behind our found power of rhinovirus suppressing COVID-19. We discuss that the critical flaw of current mathematical models originates in the absence of the 0th power term of the number of infected people in the Kermack and McKendrick equation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
tomie{at}cust.edu.cn
The main revisions are; Numbers on p.6 are corrected. Explanation of equations 5 and 6 on p.10 is changed.
Data Availability
All clinical data analyzed in the present paper are publicly available. The data of positive people in Tokyo are from the Tokyo Metropolitan Government Corona Virus Infection Control Site. The positive rate is from the file in Monitoring item (4) Positive rate of test. We calculated the age distribution using the data in Attributes of positive people. The data on rhinovirus is from the file in the Archive of Other Viruses at the site of Infectious Agents Surveillance Report (IASR) at the National Institute of Infectious Disease.
